ISRCTN26548981Completed未知
A 2x2 factorial 12-month randomised trial to evaluate the effectiveness of two integrated home-based interventions in environmental health and early child development for improving health and child development in children under 36 months living in rural Andean communities (IHIP-2)
niversidad Peruana Cayetano Heredia0 sites317 target enrollmentStarted: January 15, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 317
Study Overview
Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32241260 results (added 06/04/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35668472/ (added 07/06/2022)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Families eligible for the trial must comply with all of the following at recruitment:
- •1. Have at least one child <20 months living in the home
- •2. Use solid fuels as main energy source for cooking/heating
- •3. Have access to piped water in the yard or the community where the kitchen connections can be made
- •4. Do not plan to move within the next 24 months
Exclusion Criteria
- •1. Participate in the Peruvian national programme on early child development (PNCM)
- •2. The child has any congenital or chronic disease
- •3. Refusal to participate
Investigators
Similar Trials
Active, not recruiting
Phase 2
Radiotherapy combined with immunotherapy in metastatic non-small cell lung cancer patientsAdvanced non-small cell lung cancer, stage IVMalignant neoplasm the lung, non-small cell lung cancerCancerISRCTN49817477Maastricht University88
Completed
Not Applicable
Clinical trial for proving the efficacy of heat-inactivated Bifidobacterium bifidum SYN-HI-001 in the treatment of irritable bowel syndromeIrritable bowel syndrome (IBS)Digestive SystemISRCTN14066467Synformulas GmbH507
Completed
Phase 2
A Phase II, randomised, placebo-controlled study of paclitaxel in combination with the AKT inhibitor AZD5363 in triple-negative advanced or metastatic breast cancerCancerISRCTN64193273Queen Mary University of London (UK)140
Completed
Phase 2
The efficacy, safety and tolerability of PSD502 in subjects with premature ejaculation (PE)Premature ejaculationISRCTN57186091Plethora Solutions Ltd (UK)256
Completed
Phase 2
stekinumab in adolescents with recent-onset type 1 diabetesNutritional, Metabolic, EndocrineType 1 diabetes mellitusISRCTN14274380Cardiff University88